Evidence map›Paper›PMID 42722974›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2026

Dysregulation of Sphingolipid Metabolism in Non-Obstructive Azoospermia: Insights from Bioinformatics and a Busulfan-Induced Mouse Model.

Mojdeh Parvini, Fatemeh Ghasemian, Siamak Salimy

Abstract read
PubMed Publisher
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mojdeh ParviniDepartment of Biology, Faculty of Sciences, University of Guilan, Rasht, Iran.
Fatemeh GhasemianDepartment of Biology, Faculty of Sciences, University of Guilan, Rasht, Iran. Ghasemian@guilan.ac.ir.ORCID http://orcid.org/0000-0001-9284-6545
Siamak SalimyDepartment of Bioinformatics, University of Tehran, P.O. Box, Tehran, 41335-1914, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sphingolipid metabolism plays an important role in regulating essential cellular processes, including apoptosis, proliferation, differentiation, and cellular signaling, which are critical for normal spermatogenesis. However, the contribution of sphingolipid metabolic alterations to male infertility, particularly azoospermia, remains insufficiently understood. This study aimed to investigate the involvement of sphingolipid metabolism-related genes and metabolites in spermatogenic failure and their potential association with azoospermia. A publicly available human microarray dataset (GSE9210), consisting of testicular tissue samples from patients with obstructive azoospermia (OA; n = 11) and non-obstructive azoospermia (NOA; n = 47), was analyzed to identify differentially expressed sphingolipid metabolism-related genes. Candidate genes identified through bioinformatic analysis were further evaluated in a busulfan-induced mouse model of azoospermia (control group, n = 8; busulfan-treated group, n = 8) using quantitative real-time PCR, immunohistochemical analysis, and high-performance liquid chromatography (HPLC). Analysis of the GSE9210 dataset identified 23 differentially expressed sphingolipid metabolism-related genes between OA and NOA samples. Validation in busulfan-treated testes indicated significant dysregulation of key sphingolipid-related genes, including decreased expression of Asah1, Asah2, Acer1, Acer2, Cerk, Elovl1, Sgms1, and Galc, and increased expression of Smpd 1,2 & 3 (p < 0.05). HPLC analysis revealed significant reductions in ceramide species (Cer14, Cer16, Cer18, and Cer20), sphingosine, and sphingosine-1-phosphate levels in busulfan-treated testes (p < 0.05). Furthermore, immunohistochemical analysis showed increased expression of the inflammatory markers MMP-2 and MMP-9, accompanied by elevated levels of cleaved Caspase-3 and reduced expression of the anti-apoptotic protein Bcl-2 in the busulfan-treated group (p < 0.05). Overall, these findings suggest that disruption of sphingolipid metabolism may contribute to impaired spermatogenesis and azoospermia. Altered sphingolipid-related gene expression and metabolite profiles provide new insights into the molecular mechanisms underlying male infertility and may represent potential targets for future therapeutic investigation.

Indexed as

AzoospermiaBusulfanCeramideSpermatogenesisSphingolipidsSphingosine-1-phosphate

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.